Midwest Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.1M Sell
94,896
-304
-0.3% -$59.7K 0.23% 106
2026
Q1
$18.7M Sell
95,200
-300
-0.3% -$58.3K 0.23% 106
2025
Q4
$16.6M Buy
95,500
+927
+1% +$169K 0.21% 111
2025
Q3
$18M Sell
94,573
-5,691
-6% -$1.01M 0.23% 104
2025
Q2
$18M Buy
+100,264
New +$17.4M 0.25% 102

Other funds holding DGX

Midwest Trust's DGX Position: Q2 2026 in Review

Midwest Trust reduced its Quest Diagnostics (DGX) stake by 0.32% in Q2 2026, selling an estimated $59.7K and leaving 94,896 shares worth $20.1M. The position accounts for 0.23% of the portfolio, ranked #106.

Midwest Trust first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Midwest Trust held 94,896 shares of Quest Diagnostics worth $20.1M as of Q2 2026.
  • Midwest Trust sold 304 Quest Diagnostics shares in Q2 2026, an estimated $59.7K.
  • Quest Diagnostics made up 0.23% of Midwest Trust's portfolio in Q2 2026, its #106 holding.
  • Midwest Trust first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.